Ex-Drug Executive Shkreli Invokes Fifth Amendment Before Congress
Former Turing Pharmaceuticals Chief Executive Officer Martin Shkreli invoked his Fifth Amendment right against self-incrimination and declined to answer questions from U.S. lawmakers.
How Nancy Reagan Changed the Way Americans View Alzheimer’s
Former first lady Nancy Reagan was a ‘true champion’ of Alzheimer’s disease.
WebMD Removes 'Interim' Title From CEO, Taps President
WebMD elevated David Schlanger to the permanent CEO position after the company veteran served a three-month stint as interim CEO.
Apple Wants to Transform Your Doctor Visits
On Wednesday, Apple executives spoke about how their new Apple Watch is going to change health care.
BlackBerry Buys Minority Stake In Health-Care Cloud Firm
BlackBerry bought a minority stake in health IT firm NantHealth in a bid to improve data sharing and communication in the health-care industry.
British court rules in favor of patent protecting Lilly lung cancer treatment Alimta
Eli Lilly received some European legal backing for its top product, the lung cancer treatment Alimta, on Thursday when a British court upheld a patent protecting a vitamin regimen administered with the drug.
Unreleased financials freeze shares of Morgan Stanley-backed companies
Two major companies in a prominent $1.4 billion Asia investment fund managed by banking giant Morgan Stanley failed to file their financial statements on time, freezing trading in their stocks.
Merck gives free license allowing cheap versions of its HIV drug for children in poor nations
Drugmaker Merck has granted a free license allowing one of its HIV medicines to be made and sold inexpensively for use in young children in poor countries hard hit by the AIDS virus.
Supreme Court sides with Teva in patent dispute over multiple sclerosis drug
The Supreme Court has sided with Teva Pharmaceutical Industries Ltd. in the company's high-profile patent dispute with rival firms over the top-selling multiple sclerosis drug.
FDA drug approvals hit highest level since 1996 on record-number of specialty drugs
The Food and Drug Administration approved 41 first-of-a-kind drugs in 2014, including a record number of medicines for rare diseases, pushing the agency's annual tally of drug approvals to its highest level in 18 years.
Merck pledges commitment to $8.4 billion Cubist deal after court ruling on Cubicin patents
Merck remains committed to its $8.4 billion acquisition of Cubist Pharmaceuticals even though a federal court invalidated most of the company's patents protecting its top-selling antibiotic just hours after the deal was announced this week.
Pfizer beats Wall Street estimates with 3Q growth of drugs and vaccines in emerging markets
Pfizer reported better-than-expected third quarter earnings Tuesday as higher sales in emerging markets like China helped offset missing revenue from former blockbuster drugs that have lost patent protection.
Drugmaker Pfizer, aiming to raise sales of its Viagra, starts new ad campaign targeting women
The maker of the world's top-selling erectile dysfunction drug on Tuesday will begin airing the first Viagra TV commercial that targets the less-obvious sufferers of the sexual condition: women.
M&A Hits $4 Trillion At Fastest Pace on Record, Activision's Candy Crush King Deal Latest
CEOs have the urge to merge as global M&A hits $4 trillion for just the second time in history topped off by Activision's $6 billion purchase of Candy Crush maker King.
Indiana medical software company reports hack exposed information on 3.9M people across US
An Indiana medical software company has reported the private information of 3.9 million people nationwide was exposed when its networks were hacked earlier this year.
Recalls This Week: Bean Bag Chairs, Toy Monkeys
Bean bag chairs that can trap kids are among this week's recalled consumer products.
AbbVie, Shire, Bank of America, Lakeland Industries and Petrobras are big market movers
Stocks that moved substantially or traded heavily Wednesday on the New York Stock Exchange and the Nasdaq Stock Market: NYSE AbbVie Inc., up 50 cents to $54.63 The pharmaceutical company is reconsidering its $55 billion buyout of Shire, putting it at risk of paying a $1.6 billion fee.
Hewlett-Packard Recalls More Than 5 Million AC Power Cords for Notebook Computers
Hewlett-Packard Company is recalling about 5.6 million notebook computer AC power cords in this country and another 446,700 in Canada because of possible overheating, which can pose a fire and burn hazard.
Cerner inks deal to buy Seimens' health information technology unit for $1.3 billion
Health information technology company Cerner Corp. is buying the health information technology business unit of German industrial conglomerate Siemens AG for $1.3 billion in cash.
Researchers using iPhones to collect data on Parkinson's, asthma, other ills
Jody Kearns doesn't like to spend time obsessing about her Parkinson's disease.







